Elevation Oncology Inc

NASDAQ:ELEV  
3.15
-0.19 (-5.69%)
Earnings Announcements

Elevation Oncology Reports First Quarter 2022 Financial Results

Published: 05/05/2022 11:37 GMT
Elevation Oncology Inc (ELEV) - Elevation Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress.
Qtrly Net Loss per Share $0.74.
Q1 Earnings per Share View $-0.50 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.64

More details on our Analysts Page.